• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Piramal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Piramal Ajay G
  • BSE Code : 76066.0
  • ISIN : INE0DK501011
190.65 -6 (-3.24%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    190.00

  • Today’s High

    198.00

  • Open

    198.00

  • Perv Close

    197.03

  • 52W Low

    166.00

  • 52W High

    307.90

Key Indicators

  • P/E(TTM)

    35.23

  • Mar.Cap (₹Cr.)

    25,342.12

  • Div & Yield %

    0.07

  • Book Value(₹)

    56.10

  • Debt-Equity Ratio

    -3.24

  • AGM Date

    01-Aug-2025

  • EPS

    5.41

  • P/E Ratio

    35.23

Financials Ratios

  • Debt-Equity Ratio

    0.70

  • Mar.Cap (₹Cr.)

    25,342.12

  • RONW (%)

    0.22

  • ROCE (%)

    5.40

Score Board

  • Equity (₹ in Cr.)

    1,329.25

  • BV (₹)

    56.10

  • Sales( ₹ in Cr.)

    5,285.71

  • NP (in Cr.)

    690.16

  • NP Var(%)

    78.0

  • Div%

    1.0

  • CPS (₹)

    6.90

  • EPS (₹)

    5.20

  • Traded Value (₹ in Lakhs)

    25,335.47

  • 52 Week High

    307.90

  • 52 Week Low

    166.00

  • Price BSE

    191.0

  • Price NSE

    191.00

  • Market Capital( in Cr.)

    25,335.47

  • P/C Ratio

    27.80

  • P/E Ratio

    36.80

  • Price Vs.BV

    5.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 5,285.71 4,390.11 3,443.22 3,340.42 2,938.81 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 5,285.71 4,390.11 3,443.22 3,340.42 2,938.81 -
Other Income 207.35 202.06 341.07 224.79 216.20 -
Stock Adjustments 84.57 61.62 -53.31 32.66 -57.86 -
Total Income 5,577.63 4,653.79 3,730.98 3,597.87 3,097.15 -
EXPENDITURE :            
Raw Materials 2,330.53 2,170.46 1,715.17 1,594.17 1,169.91 -
Power and Fuel Cost 131.62 112.89 107.94 83.83 68.08 -
Employee Cost 736.19 613.93 548.50 448.03 395.15 -
Other Manufacturing Expenses 284.35 251.57 259.29 299.83 252.74 -
Selling and Administration Expenses 746.69 620.04 485.63 427.82 258.75 -
Miscellaneous Expenses 100.46 64.92 182.81 59.20 117.39 -
Employee Benefit Expenses 736.19 613.93 548.50 448.03 395.15 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 4,329.84 3,833.81 3,299.34 2,912.88 2,262.02 -
Operating Profit 1,247.79 819.98 431.64 684.99 835.13 -
Interest 114.56 107.10 115.87 57.29 4.71 -
Gross Profit 1,133.23 712.88 315.77 627.70 830.42 -
Depreciation 222.09 205.26 192.08 165.37 143.64 -
Profit Before Tax 911.14 507.62 123.69 462.33 686.78 -
Current Tax 199.44 112.48 38.77 110.82 104.98 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 20.30 3.92 15.42 -16.03 10.30 -
Reported Net Profit 691.40 391.22 69.50 367.54 571.50 -
Extraordinary Items 1.24 3.34 -3.14 -10.64 15.44 -
Adjusted Net Profit 690.16 387.88 72.64 378.18 556.06 -
Adjustment below Net Profit 1.05 -3.79 -2.59 31.70 -2.46 -
P & L Balance brought forward 1,359.23 971.79 918.28 569.04 0.00 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 14.47 0.00 13.40 50.00 0.00 -
P & L Balance carried down 2,037.21 1,359.22 971.79 918.28 569.04 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 1.40 1.10 0.00 5.60 0.00 -
Dividend Per Share(Rs) 0.14 0.11 0.00 0.56 0.00 -
Earnings Per Share-Unit Curr 5.22 2.96 0.58 3.10 5.75 -
Earnings Per Share(Adj)-Unit Curr 5.22 2.96 0.57 - - -
Book Value 56.27 50.74 44.09 43.20 41.23 -
Book Value(Adj)-Unit Curr 56.27 50.74 43.06 - - -

Shareholding Pattern

  • Promoter Group

    34.86%

  • Public Share Holding

    64.57%

  • Custodian

    0.57%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,570,932 0.19 2,570,932 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 460,753,740 34.66 460,753,740 8
Sub Total 463,324,672 34.86 463,324,672 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 4,441 0.00 4,441 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 238,663,700 17.95 238,663,700 1
Financial Institutions / Banks 9,868 0.00 9,868 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 171,600,874 12.91 171,600,874 176
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 1,332 0.00 1,332 1
Insurance Companies 22,207,908 1.67 22,207,908 13
Mutual Funds / UTI 163,795,423 12.32 163,795,423 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,489,892 0.26 3,489,892 25
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 599,773,438 45.12 599,773,438 247
2] Non Institution
Bodies Corporate 16,850,466 1.27 16,850,466 1,330
Clearing Members 100,558 0.01 100,558 12
Directors of their Relatives 228,668 0.02 228,668 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 17,315,548 1.30 17,315,548 2
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 14,073,182 1.06 14,073,182 6,562
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 5,580,562 0.42 5,580,562 5,846
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 47,811,466 3.60 47,811,466 703
Individuals holding nominal share capital up to Rs. 1 lakh 139,273,283 10.48 139,272,663 443,549
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 73,664 0.01 73,664 16
Others 3,228,564 0.24 3,228,564 1
Sub Total 258,580,839 19.45 258,580,219 458,163
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 7,569,181 0.57 7,569,181 3
Total Shares held by Custodians and against which Depository Receipts have been issued 7,569,181 0.57 7,569,181 3
Grand Total ( A + B + C ) 1,329,248,130 100.00 1,329,247,510 458,430

Company Background

Piramal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Piramal Pharma Ltd
  • BSE Code : 76066.0
  • ISIN : INE0DK501011

  • Incorporation Year

    2020

  • Registered Office

    Ground Floor Piramal Ananta
    Agastya Corp.Park LBS MargKurl, Mumbai,
    Maharashtra-400070

  • Telephone

    91-22-3802-3000/4000

  • FAX

    91-22-3802 3884

  • Chairman

    Nandini Piramal

  • Managing Director

  • Company Secretary

    Tanya D'Costa

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Piramal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Piramal Pharma 190.60 5,493.06 5,285.71 35.23 12.31
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10